Dianthus Therapeutics, Inc. (DNTH)
90.50
+3.02
(+3.45%)
USD |
NASDAQ |
Apr 09, 14:00
Dianthus Therapeutics Total Liabilities (Quarterly) : 38.00M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Madrigal Pharmaceuticals, Inc. | 656.90M |
| Sarepta Therapeutics, Inc. | 2.209B |
| Daré Bioscience, Inc. | 29.63M |
| Relmada Therapeutics, Inc. | 7.492M |
| Viridian Therapeutics, Inc. | 177.25M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 531.40M |
| Shareholders Equity (Quarterly) | 493.40M |
| Debt to Equity Ratio | 0.0028 |
| Current Ratio | 13.32 |
| Net Debt Paydown Yield | -0.01% |